Search research articles
Contact Us
Filters
Showing results (11-20 of 249) with videos related to
Page
of 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
November 13, 2012
Early-stage non-small cell lung cancer in elderly patients: should stereotactic radiation therapy be the standard of care?
David A Palma, Suresh Senan
Clinical Lung Cancer
|
August 1, 2012
Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy
David A Palma, Suresh Senan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 14, 2024
Response to evaluation of post-lung SABR imaging: A proposed pathway
Stephanie Gulstene, David A Palma
International Journal of Radiation Oncology, Biology, Physics
|
March 19, 2026
Recovery at the Edge of the Limits
Niall O'Dwyer, David A Palma
BMJ Oncology
|
June 12, 2026
Treatment of oligometastatic lung cancers: new data, new drivers, new approaches
Niall O'Dwyer, David A Palma
Cancer Research and Treatment
|
December 25, 2022
Top Ten Lessons Learned from Trials in Oligometastatic Cancers
Vivian S Tan, David A Palma
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2026
EXTENDing the Role of Radiation in Oligometastatic Disease
Vivian S Tan, David A Palma
Advances in Radiation Oncology
|
February 14, 2020
In Response to Grégoire et al
Mark T Corkum, David A Palma
Translational Lung Cancer Research
|
February 3, 2017
Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapy
Timothy K Nguyen, David A Palma
NEJM Evidence
|
February 6, 2024
Should Stereotactic Ablative Radiotherapy Be Used for Oligometastatic Disease?
Robert A Olson, David A Palma
Page
of 25
Search research articles
Search
Showing results (11-20 of 249) with videos related to
Sort By:
Page
of 25
International Journal of Radiation Oncology, Biology, Physics
|
November 13, 2012
Early-stage non-small cell lung cancer in elderly patients: should stereotactic radiation therapy be the standard of care?
David A Palma, Suresh Senan
Clinical Lung Cancer
|
August 1, 2012
Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy
David A Palma, Suresh Senan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 14, 2024
Response to evaluation of post-lung SABR imaging: A proposed pathway
Stephanie Gulstene, David A Palma
International Journal of Radiation Oncology, Biology, Physics
|
March 19, 2026
Recovery at the Edge of the Limits
Niall O'Dwyer, David A Palma
BMJ Oncology
|
June 12, 2026
Treatment of oligometastatic lung cancers: new data, new drivers, new approaches
Niall O'Dwyer, David A Palma
Cancer Research and Treatment
|
December 25, 2022
Top Ten Lessons Learned from Trials in Oligometastatic Cancers
Vivian S Tan, David A Palma
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2026
EXTENDing the Role of Radiation in Oligometastatic Disease
Vivian S Tan, David A Palma
Advances in Radiation Oncology
|
February 14, 2020
In Response to Grégoire et al
Mark T Corkum, David A Palma
Translational Lung Cancer Research
|
February 3, 2017
Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapy
Timothy K Nguyen, David A Palma
NEJM Evidence
|
February 6, 2024
Should Stereotactic Ablative Radiotherapy Be Used for Oligometastatic Disease?
Robert A Olson, David A Palma
Page
of 25